Segall Bryant & Hamill International Equity Fund - Institutional Class CIEQX

Medalist Rating as of | See Segall Bryant & Hamill Investment Hub
  • NAV / 1-Day Return 15.60  /  −0.38 %
  • Total Assets 14.4M
  • Adj. Expense Ratio
    0.840%
  • Expense Ratio 0.860%
  • Distribution Fee Level Average
  • Share Class Type Institutional
  • Category Foreign Large Value
  • Investment Style Large Value
  • Min. Initial Investment 250,000
  • Status Open
  • TTM Yield 1.36%
  • Turnover 107%

USD | NAV as of Jul 18, 2026 | 1-Day Return as of Jul 18, 2026, 12:43 AM GMT+0

Morningstar’s Analysis CIEQX

Will CIEQX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

Segall Bryant & Hamll Intl Eq Inst holds a quantitatively derived Bronze Morningstar Medalist Rating. The rating reflects that it has scored better than the norm on factors Morningstar research associates with future outperformance relative to category peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings CIEQX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 15.6
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Roche Holding AG Ordinary Shares new

2.35 345,064
Healthcare

ASML Holding NV

1.85 271,689
Technology

Novartis AG Registered Shares

1.57 230,010
Healthcare

BNP Paribas Act. Cat.A

1.55 226,833
Financial Services

Banco Bilbao Vizcaya Argentaria SA

1.48 216,832
Financial Services

GSK PLC

1.45 212,500
Healthcare

Kioxia Holdings Corp Ordinary Shares

1.40 205,894
Technology

UniCredit SpA

1.34 196,298
Financial Services

NatWest Group PLC

1.31 192,799
Financial Services

Infineon Technologies AG

1.28 187,386
Technology

Sponsor Center